US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Takeda Pharmaceutical Co Ltd

17.89

+0.09000.51%

Post-market: 17.900.0100+0.06%18:53 EST

Volume:3.13M

Turnover:56.13M

Market Cap:56.52B

PE:79.61

High:17.99

Open:17.79

Low:17.70

Close:17.80

52wk High:17.99

52wk Low:12.99

Shares:3.16B

Float Shares:3.06B

Volume Ratio:0.81

T/O Rate:0.10%

Dividend:0.63

Dividend Rate:3.53%

EPS(TTM):0.2247

EPS(LYR):0.2245

ROE:1.50%

ROA:2.47%

PB:1.16

PE(LYR):79.70

Loading ...

Overview Company News Filings

Takeda’s TAK-188 Trial: Early Immunotherapy Bet in Advanced Solid Tumors

Takeda Advances TAK-360 Sleep Disorder Trial, Signaling Growing Ambition in Orexin-Based Therapies

Takeda Advances TAK-279 in Ulcerative Colitis: What Investors Should Watch Next

Takeda Flags Vyvanse Hit, Lifts 2025 Profit Guidance On Cost Control

Takeda raises FY25 core EPS view to 486 yen from 479 yen

Takeda reports Q3 core EPS 428 yen vs. 443 yen last year

Takeda Pharmaceutical Q3 Adj. EPS $0.47 Misses $0.55 Estimate, Sales $7.600B Miss $8.530B Estimate

Press Release: Takeda Reports Third-Quarter FY2025 Results: Updates Full Year Outlook to Reflect VYVANSE(R) Generics Impact, OPEX Discipline and FX Tailwind; Progressing Toward Three Transformative Launches Ahead

Medicare is about to start negotiating the prices of medications administered by doctors

Takeda Expected to Report Sharply Higher Third-Quarter Net Profit -- Earnings Preview

Takeda Advances TAK-861 Into Phase 3 for Narcolepsy With Cataplexy, Setting Up a New CNS Catalyst

Takeda's (TAK.US) New Class 1 Drug Oveporexton Tablets Recommended for Priority Review, Intended for Type 1 Narcolepsy Patients

Takeda Pharmaceutical Launches Liquid Medicine for Primary Immunodeficiency in US

MT Newswires Live

Earning Preview: Takeda Pharmaceutical Co Ltd — this quarter’s revenue is expected to increase by 6.05%, and institutional views are constructive

Takeda’s TAK-411 CIDP Study Progresses: What Investors Should Watch

Takeda Pharmaceutical's (TAK.US) New Class 1 Drug "Oboletong Tablets" Files for Market Approval in China

Oncolytics Biotech® Appoints John McAdory as EVP of Strategy and Operations and Yujun Wu to Lead Biostatistics

Leerink views ‘major deal’ on Entyvio as positive for Halozyme

Halozyme announces global collaboration, license agreement with Takeda

Takeda Pharmaceuticals Shares Rise on Positive Psoriasis Treatment Results

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/TAK/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"TAK","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TAK\",,,,,undefined,":{"symbol":"TAK","market":"US","secType":"STK","nameCN":"Takeda Pharmaceutical Co Ltd","latestPrice":17.89,"timestamp":1770411600000,"preClose":17.8,"halted":0,"volume":3133923,"hourTrading":{"tag":"盘后","latestPrice":17.9,"preClose":17.89,"latestTime":"18:53 EST","volume":1560,"amount":27899.05,"timestamp":1770422013510,"change":0.01,"changeRate":0.000559,"amplitude":0},"delay":0,"changeRate":0.005056179775280891,"floatShares":3057000000,"shares":3159188548,"eps":0.224727,"marketStatus":"Market Closed","change":0.09,"latestTime":"02-06 16:00:00 EST","open":17.79,"high":17.985,"low":17.7,"amount":56127736.708251,"amplitude":0.016011,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.224727,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"adrRate":0.5,"listingDate":1545627600000,"exchange":"NYSE","adjPreClose":17.8,"dividendRate":0.035372,"preHourTrading":{"tag":"盘前","latestPrice":17.78,"preClose":17.8,"latestTime":"09:01 EST","volume":210,"amount":3699.3201,"timestamp":1770386510124,"change":-0.02,"changeRate":-0.001124,"amplitude":0.019101},"postHourTrading":{"tag":"盘后","latestPrice":17.9,"preClose":17.89,"latestTime":"18:53 EST","volume":1560,"amount":27899.05,"timestamp":1770422013510,"change":0.01,"changeRate":0.000559,"amplitude":0},"volumeRatio":0.8088237874629594,"impliedVol":0.3935,"impliedVolPercentile":0.757},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TAK\",,,,,undefined,":{"symbol":"TAK","floatShares":3057000000,"roa":"2.47%","roe":"1.50%","lyrEps":0.224477,"volumeRatio":0.8088237874629594,"shares":3159188548,"dividePrice":0.631422,"high":17.985,"amplitude":0.016011,"preClose":17.8,"low":17.7,"week52Low":12.99,"pbRate":"1.16","psRate":"1.98","week52High":17.985,"institutionHeld":0.1079,"latestPrice":17.89,"eps":0.224727,"divideRate":0.035295,"volume":3133923,"delay":0,"ttmEps":0.224727,"open":17.79,"prevYearClose":15.59,"prevWeekClose":17.23,"prevMonthClose":17.23,"prevQuarterClose":15.59,"fiveDayClose":17.23,"twentyDayClose":16.37,"sixtyDayClose":13.71},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TAK\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-01-29","symbol":"TAK","fiscalQuarterEnding":"2025/12","expectedEps":0.55,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1769662800000,"reportTimeType":"pre","actualEps":0.48},{"date":"2025-10-30","symbol":"TAK","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/09","expectedEps":0.44,"defaultRemindTime":1761811200000,"name":null,"time":"Pre-Market","dateTimestamp":1761796800000,"actualEps":0.44},{"market":"US","date":"2025-07-30","symbol":"TAK","fiscalQuarterEnding":"2025/06","expectedEps":0.47,"name":null,"time":"","type":"earning","dateTimestamp":1753848000000,"reportTimeType":"","actualEps":0.52},{"market":"US","date":"2025-01-30","symbol":"TAK","fiscalQuarterEnding":"2024/12","expectedEps":0.34,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1738213200000,"reportTimeType":"pre","actualEps":0.42},{"market":"US","date":"2024-10-31","symbol":"TAK","fiscalQuarterEnding":"2024/09","expectedEps":0.39,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730347200000,"reportTimeType":"pre","actualEps":0.44}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TAK\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TAK\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1689224400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TAK\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TAK","date":"2026-02-06","current":79.607702,"percent":0.9504,"low":9.919003,"twenty":15.819699,"median":29.842804,"eighty":45.118598,"high":247.195474,"avg":39.419043,"sd":43.533059,"marketCap":55518181293.68},"quantilePoints":[{"date":"2021-02-12","current":31.919516,"twenty":30.223066,"median":43.441886,"eighty":92.526232,"marketCap":54935581599.54},{"date":"2021-02-19","current":31.997411,"twenty":30.238705,"median":43.337626,"eighty":92.438506,"marketCap":54757645997.71},{"date":"2021-02-26","current":31.00209,"twenty":30.269781,"median":42.961129,"eighty":92.297171,"marketCap":52506642547.95},{"date":"2021-03-05","current":32.525364,"twenty":30.307584,"median":42.874245,"eighty":92.272802,"marketCap":54273339139.55},{"date":"2021-03-12","current":34.741035,"twenty":30.314105,"median":42.671516,"eighty":92.258181,"marketCap":57572160306.5},{"date":"2021-03-19","current":36.991326,"twenty":30.320622,"median":42.376112,"eighty":92.258181,"marketCap":61377881020.81},{"date":"2021-03-26","current":36.385479,"twenty":30.34278,"median":42.069006,"eighty":92.219192,"marketCap":59972674222.12},{"date":"2021-04-01","current":35.38287,"twenty":30.371454,"median":41.476727,"eighty":92.150961,"marketCap":57783874962.89},{"date":"2021-04-09","current":32.481215,"twenty":30.393667,"median":38.431569,"eighty":92.111972,"marketCap":53478879478.89},{"date":"2021-04-16","current":32.082779,"twenty":30.470959,"median":38.377853,"eighty":92.111972,"marketCap":53250001858.4},{"date":"2021-04-23","current":31.900884,"twenty":30.513064,"median":38.294386,"eighty":92.058362,"marketCap":53341682665.94},{"date":"2021-04-30","current":31.485125,"twenty":30.533079,"median":38.21414,"eighty":91.833434,"marketCap":52029509066.16},{"date":"2021-05-07","current":31.831591,"twenty":30.534382,"median":38.169603,"eighty":91.791488,"marketCap":52970833572.63},{"date":"2021-05-14","current":15.564762,"twenty":30.470959,"median":38.145677,"eighty":91.758112,"marketCap":53496176267.97},{"date":"2021-05-21","current":15.876889,"twenty":30.319318,"median":38.091991,"eighty":91.609986,"marketCap":54795356598.76},{"date":"2021-05-28","current":15.664642,"twenty":30.236167,"median":38.041392,"eighty":91.546628,"marketCap":53587690959.61},{"date":"2021-06-04","current":15.281766,"twenty":30.057838,"median":37.818162,"eighty":91.527134,"marketCap":52499044333.6},{"date":"2021-06-11","current":15.732274,"twenty":29.940017,"median":37.70687,"eighty":91.283451,"marketCap":53886220157.49},{"date":"2021-06-18","current":15.499142,"twenty":29.705398,"median":37.644832,"eighty":91.259083,"marketCap":52855138856.99},{"date":"2021-06-25","current":15.64495,"twenty":29.653254,"median":37.496711,"eighty":91.185978,"marketCap":53110087882.29},{"date":"2021-07-02","current":15.624135,"twenty":29.556114,"median":37.309512,"eighty":90.966664,"marketCap":52790633079.89},{"date":"2021-07-09","current":15.170356,"twenty":29.369182,"median":37.239049,"eighty":90.713234,"marketCap":51765371608.86},{"date":"2021-07-16","current":15.553362,"twenty":29.036801,"median":37.034171,"eighty":90.649877,"marketCap":53089153550.44},{"date":"2021-07-23","current":15.445121,"twenty":28.610503,"median":36.990446,"eighty":90.630383,"marketCap":52540828243.5},{"date":"2021-07-30","current":13.400212,"twenty":26.987384,"median":36.968687,"eighty":90.397999,"marketCap":52641482781.37},{"date":"2021-08-06","current":13.231512,"twenty":25.788836,"median":36.881192,"eighty":90.295707,"marketCap":51739766156.6},{"date":"2021-08-13","current":13.399277,"twenty":25.542527,"median":36.851251,"eighty":90.284353,"marketCap":52624385513.69},{"date":"2021-08-20","current":13.340924,"twenty":25.375364,"median":36.822486,"eighty":90.167386,"marketCap":52391869685.63},{"date":"2021-08-27","current":13.304453,"twenty":25.07978,"median":36.81694,"eighty":90.040671,"marketCap":52184954198.97},{"date":"2021-09-03","current":13.585277,"twenty":24.895379,"median":36.800541,"eighty":89.938325,"marketCap":53414238064.1},{"date":"2021-09-10","current":13.6801,"twenty":24.732641,"median":36.787118,"eighty":89.91883,"marketCap":53684261064.92},{"date":"2021-09-17","current":13.906217,"twenty":24.583535,"median":36.72461,"eighty":89.874967,"marketCap":54565644835.19},{"date":"2021-09-24","current":13.753041,"twenty":24.444102,"median":36.66065,"eighty":89.831104,"marketCap":53563443001.25},{"date":"2021-10-01","current":13.260689,"twenty":24.187434,"median":36.617455,"eighty":89.777494,"marketCap":51482210756.95},{"date":"2021-10-08","current":11.666926,"twenty":23.93319,"median":36.601121,"eighty":89.748252,"marketCap":44862900501.13},{"date":"2021-10-15","current":11.787279,"twenty":23.7033,"median":36.578836,"eighty":89.499696,"marketCap":44516597060.99},{"date":"2021-10-22","current":11.681514,"twenty":23.539863,"median":36.5454,"eighty":88.968468,"marketCap":44293684279.19},{"date":"2021-10-29","current":10.648321,"twenty":23.423498,"median":36.488155,"eighty":88.710165,"marketCap":44164269191.12},{"date":"2021-11-05","current":10.784625,"twenty":23.226892,"median":36.468627,"eighty":88.627312,"marketCap":44983557825.66},{"date":"2021-11-12","current":10.950849,"twenty":22.951173,"median":36.398869,"eighty":88.490851,"marketCap":45493195113.2},{"date":"2021-11-19","current":10.728109,"twenty":22.593579,"median":36.365388,"eighty":88.33002,"marketCap":44596449686.83},{"date":"2021-11-26","current":10.425581,"twenty":22.055183,"median":36.25968,"eighty":88.252042,"marketCap":43512424769.26},{"date":"2021-12-03","current":10.106651,"twenty":21.515452,"median":36.172679,"eighty":88.178937,"marketCap":42286529642.36},{"date":"2021-12-10","current":10.142864,"twenty":21.321368,"median":36.088488,"eighty":87.847529,"marketCap":42348534488.31},{"date":"2021-12-17","current":10.34424,"twenty":21.015505,"median":36.02197,"eighty":87.423521,"marketCap":43082485607.36},{"date":"2021-12-23","current":10.363994,"twenty":20.795645,"median":35.82744,"eighty":87.174965,"marketCap":42874132957.12},{"date":"2021-12-31","current":10.327779,"twenty":20.657578,"median":35.632629,"eighty":86.517022,"marketCap":42437110052.52},{"date":"2022-01-07","current":10.522022,"twenty":20.640925,"median":35.562823,"eighty":86.434171,"marketCap":43033429977.32},{"date":"2022-01-14","current":11.009273,"twenty":20.536864,"median":35.556871,"eighty":86.322076,"marketCap":45750368973.66},{"date":"2022-01-21","current":10.940136,"twenty":20.171308,"median":35.520843,"eighty":86.263593,"marketCap":45488233052.08},{"date":"2022-01-28","current":10.953305,"twenty":19.949589,"median":35.455688,"eighty":85.922437,"marketCap":44994125510.56},{"date":"2022-02-04","current":12.019761,"twenty":19.86233,"median":35.393845,"eighty":85.355005,"marketCap":45736794370.02},{"date":"2022-02-11","current":12.502153,"twenty":19.831282,"median":35.308236,"eighty":85.302091,"marketCap":47298200126.65},{"date":"2022-02-18","current":12.558981,"twenty":19.671006,"median":35.308236,"eighty":85.302091,"marketCap":47834673171.52},{"date":"2022-02-25","current":12.196703,"twenty":19.550551,"median":35.308236,"eighty":85.302091,"marketCap":46263555485.74},{"date":"2022-03-04","current":12.289048,"twenty":19.380891,"median":35.308236,"eighty":85.302091,"marketCap":46976698663.99},{"date":"2022-03-11","current":12.043978,"twenty":19.117196,"median":35.308236,"eighty":85.302091,"marketCap":45095629553.81},{"date":"2022-03-18","current":12.707196,"twenty":18.980245,"median":35.308236,"eighty":85.302091,"marketCap":46769031069.82},{"date":"2022-03-25","current":12.770838,"twenty":18.858799,"median":35.308236,"eighty":85.302091,"marketCap":45895036970.15},{"date":"2022-04-01","current":12.530413,"twenty":18.69121,"median":35.308236,"eighty":85.302091,"marketCap":44742437445.66},{"date":"2022-04-08","current":13.064299,"twenty":18.623126,"median":35.308236,"eighty":85.302091,"marketCap":46073289723.14},{"date":"2022-04-14","current":13.294114,"twenty":18.443795,"median":35.308236,"eighty":85.302091,"marketCap":46294767383.12},{"date":"2022-04-22","current":13.21633,"twenty":18.221438,"median":35.308236,"eighty":85.302091,"marketCap":45025239824.55},{"date":"2022-04-29","current":13.325935,"twenty":17.979017,"median":35.308236,"eighty":85.302091,"marketCap":45022632781.95},{"date":"2022-05-06","current":13.53454,"twenty":17.700642,"median":35.308236,"eighty":85.302091,"marketCap":45566277364},{"date":"2022-05-13","current":24.629857,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":43848144051.53},{"date":"2022-05-20","current":25.018997,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":45016426783.75},{"date":"2022-05-27","current":25.119636,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":45470626890.48},{"date":"2022-06-03","current":24.280973,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":42728413394.89},{"date":"2022-06-10","current":24.368194,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":41777808638.38},{"date":"2022-06-17","current":23.83145,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":40560767412.66},{"date":"2022-06-24","current":24.871564,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":42352646298.73},{"date":"2022-07-01","current":25.220478,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":42911856821.29},{"date":"2022-07-08","current":26.059148,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":44046297256.04},{"date":"2022-07-15","current":26.763631,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":44459950529.79},{"date":"2022-07-22","current":26.817305,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":45321441244.41},{"date":"2022-07-29","current":30.743571,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":45477961048.28},{"date":"2022-08-05","current":29.247514,"twenty":15.868566,"median":35.251678,"eighty":85.31532,"marketCap":42639852719.36},{"date":"2022-08-12","current":29.748811,"twenty":15.868566,"median":35.071486,"eighty":85.31532,"marketCap":43951767417.68},{"date":"2022-08-19","current":29.8898,"twenty":15.868566,"median":34.741035,"eighty":85.31532,"marketCap":43038704613},{"date":"2022-08-26","current":29.874135,"twenty":15.868566,"median":33.797644,"eighty":85.31532,"marketCap":42969756201.7},{"date":"2022-09-02","current":30.022957,"twenty":15.868566,"median":32.525364,"eighty":85.31532,"marketCap":42304023842.38},{"date":"2022-09-09","current":30.65741,"twenty":15.868566,"median":32.307982,"eighty":85.31532,"marketCap":42457872052.31},{"date":"2022-09-16","current":30.406762,"twenty":15.868566,"median":32.13589,"eighty":85.31532,"marketCap":41975860478.2},{"date":"2022-09-23","current":29.784868,"twenty":15.868566,"median":32.082779,"eighty":85.31532,"marketCap":41053322910.74},{"date":"2022-09-30","current":29.611929,"twenty":15.868566,"median":31.991351,"eighty":85.31532,"marketCap":40398024705.55},{"date":"2022-10-07","current":29.784868,"twenty":15.868566,"median":31.910861,"eighty":85.31532,"marketCap":40490115913.28},{"date":"2022-10-14","current":30.091442,"twenty":15.868566,"median":31.822929,"eighty":85.31532,"marketCap":40007811364.69},{"date":"2022-10-21","current":29.234607,"twenty":15.868566,"median":31.680102,"eighty":85.31532,"marketCap":38943108088.84},{"date":"2022-10-28","current":27.96678,"twenty":15.868566,"median":31.562866,"eighty":85.31532,"marketCap":40412932074.34},{"date":"2022-11-04","current":27.990228,"twenty":15.868566,"median":31.51076,"eighty":85.31532,"marketCap":40544936411.09},{"date":"2022-11-11","current":28.209015,"twenty":15.868566,"median":31.374814,"eighty":85.31532,"marketCap":43206259311.05},{"date":"2022-11-18","current":28.704934,"twenty":15.868566,"median":31.254645,"eighty":85.31532,"marketCap":43730486647.27},{"date":"2022-11-25","current":29.426933,"twenty":15.868566,"median":31.201154,"eighty":85.31532,"marketCap":45057111010.77},{"date":"2022-12-02","current":28.931014,"twenty":15.868566,"median":31.037761,"eighty":85.31532,"marketCap":45570767384.44},{"date":"2022-12-09","current":29.835336,"twenty":15.868566,"median":30.937343,"eighty":85.31532,"marketCap":46637499358.3},{"date":"2022-12-16","current":30.331255,"twenty":15.868566,"median":30.871973,"eighty":85.31532,"marketCap":47313819017.43},{"date":"2022-12-23","current":29.900973,"twenty":15.868566,"median":30.772934,"eighty":85.31532,"marketCap":47996239753.01},{"date":"2022-12-30","current":29.981195,"twenty":15.868566,"median":30.71556,"eighty":85.31532,"marketCap":48463304453.77},{"date":"2023-01-06","current":29.755114,"twenty":15.868566,"median":30.572454,"eighty":85.31532,"marketCap":47870974965.36},{"date":"2023-01-13","current":29.864508,"twenty":15.868566,"median":30.484406,"eighty":85.31532,"marketCap":49882681588.13},{"date":"2023-01-20","current":30.426063,"twenty":15.868566,"median":30.426063,"eighty":85.31532,"marketCap":49943652563.58},{"date":"2023-01-27","current":30.148932,"twenty":15.868566,"median":30.406762,"eighty":85.31532,"marketCap":49467797966.47},{"date":"2023-02-03","current":23.618692,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":49524315647.28},{"date":"2023-02-10","current":23.884908,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":49885153889.85},{"date":"2023-02-17","current":23.681054,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":48373362782.36},{"date":"2023-02-24","current":23.799969,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":47942402215.74},{"date":"2023-03-03","current":24.043461,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":48450666632.88},{"date":"2023-03-10","current":24.621048,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50074775527.78},{"date":"2023-03-17","current":24.802252,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":51520828536.51},{"date":"2023-03-24","current":24.139732,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50698940566.02},{"date":"2023-03-31","current":24.63238,"twenty":15.872727,"median":30.373407,"eighty":85.302091,"marketCap":50868882296.85},{"date":"2023-04-06","current":24.898523,"twenty":15.872727,"median":30.373407,"eighty":85.302091,"marketCap":51908951328.51},{"date":"2023-04-14","current":25.289243,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":52430478946.56},{"date":"2023-04-21","current":25.436471,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":52090554629.18},{"date":"2023-04-28","current":25.549723,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":52360758781.69},{"date":"2023-05-05","current":25.934781,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":53114594501.1},{"date":"2023-05-12","current":21.816188,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":51463307525.88},{"date":"2023-05-19","current":21.919152,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50148262100.11},{"date":"2023-05-26","current":22.174322,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50264110513.18},{"date":"2023-06-02","current":21.909524,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50016322403.86},{"date":"2023-06-09","current":22.247876,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50740318667.02},{"date":"2023-06-16","current":22.419504,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50575421543.16},{"date":"2023-06-23","current":22.547244,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":50034367985.85},{"date":"2023-06-30","current":22.199081,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":48652831553.96},{"date":"2023-07-07","current":21.625347,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":47542321682.04},{"date":"2023-07-14","current":21.105555,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":48436114801.39},{"date":"2023-07-21","current":21.512562,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":48597606707.51},{"date":"2023-07-28","current":22.302484,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":47655983749.28},{"date":"2023-08-04","current":22.405905,"twenty":15.864404,"median":30.349157,"eighty":85.328548,"marketCap":47472091400.73},{"date":"2023-08-11","current":22.962958,"twenty":15.864404,"median":30.308236,"eighty":85.328548,"marketCap":47925971293.26},{"date":"2023-08-18","current":22.653484,"twenty":15.864404,"median":30.308236,"eighty":85.328548,"marketCap":46744998549.67},{"date":"2023-08-25","current":22.947484,"twenty":15.864404,"median":30.308236,"eighty":85.328548,"marketCap":47472892956.93},{"date":"2023-09-01","current":23.262116,"twenty":15.864404,"median":30.265696,"eighty":85.328548,"marketCap":48142626644.03},{"date":"2023-09-08","current":23.262116,"twenty":15.864404,"median":30.265696,"eighty":85.328548,"marketCap":47619131084.19},{"date":"2023-09-15","current":25.06738,"twenty":15.864404,"median":30.239629,"eighty":85.328548,"marketCap":51339735089.9},{"date":"2023-09-22","current":24.298853,"twenty":15.864404,"median":30.152523,"eighty":85.328548,"marketCap":49671905160.78},{"date":"2023-09-29","current":23.9378,"twenty":15.864404,"median":30.101284,"eighty":85.328548,"marketCap":48306094881.06},{"date":"2023-10-06","current":23.12801,"twenty":15.864404,"median":30.064639,"eighty":85.328548,"marketCap":46912236069.61},{"date":"2023-10-13","current":23.4478,"twenty":15.864404,"median":30.064639,"eighty":85.328548,"marketCap":47185225879.19},{"date":"2023-10-20","current":22.447168,"twenty":15.864404,"median":30.035164,"eighty":85.328548,"marketCap":45133632614.81},{"date":"2023-10-27","current":33.018744,"twenty":15.848805,"median":30.061417,"eighty":85.468491,"marketCap":42045438777.36},{"date":"2023-11-03","current":33.977052,"twenty":15.848805,"median":30.109117,"eighty":85.468491,"marketCap":43262280273.82},{"date":"2023-11-10","current":34.001614,"twenty":15.848805,"median":30.156114,"eighty":85.468491,"marketCap":43146195810.29},{"date":"2023-11-17","current":34.509223,"twenty":15.848805,"median":30.265619,"eighty":85.468491,"marketCap":43924997173.45},{"date":"2023-11-24","current":34.411351,"twenty":15.848805,"median":30.338548,"eighty":85.468491,"marketCap":44071202551.42},{"date":"2023-12-01","current":34.149357,"twenty":15.848805,"median":30.406762,"eighty":85.468491,"marketCap":44271809028.5},{"date":"2023-12-08","current":33.224188,"twenty":15.856081,"median":30.46982,"eighty":85.355005,"marketCap":44164475676.92},{"date":"2023-12-15","current":32.708387,"twenty":15.856081,"median":30.676992,"eighty":85.355005,"marketCap":44261463171.18},{"date":"2023-12-22","current":32.732997,"twenty":15.856081,"median":31.207345,"eighty":85.355005,"marketCap":44132705649.12},{"date":"2023-12-29","current":33.191488,"twenty":15.848805,"median":31.270394,"eighty":85.468491,"marketCap":45078827041.22},{"date":"2024-01-05","current":35.107326,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46553386498.52},{"date":"2024-01-12","current":35.467569,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46529118760.4},{"date":"2024-01-19","current":35.574004,"twenty":15.834252,"median":31.485125,"eighty":85.695464,"marketCap":46054562134.98},{"date":"2024-01-26","current":35.287452,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":45813893702.51},{"date":"2024-02-02","current":37.669312,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":45919514328.61},{"date":"2024-02-09","current":37.493246,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":44733412617.38},{"date":"2024-02-16","current":38.84015,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46075141205.13},{"date":"2024-02-23","current":39.033823,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46211688108.13},{"date":"2024-03-01","current":38.637675,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":45954550562.52},{"date":"2024-03-08","current":38.311953,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":46140815426.08},{"date":"2024-03-15","current":37.871788,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":45561442683.96},{"date":"2024-03-22","current":38.796134,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":45585981704.56},{"date":"2024-03-28","current":37.000261,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":43584427473.65},{"date":"2024-04-05","current":36.269795,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":42616375994.67},{"date":"2024-04-12","current":36.498683,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":42430179712.64},{"date":"2024-04-19","current":35.820825,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":41294416133.79},{"date":"2024-04-26","current":35.997119,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41249770241.05},{"date":"2024-05-03","current":36.314041,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":42076379836.26},{"date":"2024-05-10","current":36.349255,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41627594417.07},{"date":"2024-05-17","current":44.976968,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41733682877.63},{"date":"2024-05-24","current":45.020529,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41285104836.56},{"date":"2024-05-31","current":45.445251,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41644103120.04},{"date":"2024-06-07","current":46.087779,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":42404430023},{"date":"2024-06-14","current":45.107651,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41300590483.72},{"date":"2024-06-21","current":43.866156,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":39610552206.76},{"date":"2024-06-28","current":45.436656,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":40691773038.88},{"date":"2024-07-05","current":46.209907,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":41429859502.63},{"date":"2024-07-12","current":47.281654,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":43144411716.7},{"date":"2024-07-19","current":46.533596,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":42599959119.02},{"date":"2024-07-26","current":46.698609,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":43774096625.98},{"date":"2024-08-02","current":44.272889,"twenty":15.841528,"median":31.485125,"eighty":84.95809,"marketCap":45300242074.37},{"date":"2024-08-09","current":43.014896,"twenty":15.841528,"median":31.485125,"eighty":84.034079,"marketCap":44025677518.59},{"date":"2024-08-16","current":45.710595,"twenty":15.841528,"median":31.485125,"eighty":83.611233,"marketCap":46246726032.37},{"date":"2024-08-23","current":46.418876,"twenty":15.841528,"median":31.485125,"eighty":83.285679,"marketCap":48080793858.92},{"date":"2024-08-30","current":45.805737,"twenty":15.841528,"median":31.485125,"eighty":82.840382,"marketCap":47110126928.06},{"date":"2024-09-06","current":45.150312,"twenty":15.841528,"median":31.485125,"eighty":82.567216,"marketCap":47633333133.33},{"date":"2024-09-13","current":43.733749,"twenty":15.841528,"median":31.485125,"eighty":82.35018,"marketCap":46692187320.02},{"date":"2024-09-20","current":45.192598,"twenty":15.841528,"median":31.485125,"eighty":81.917164,"marketCap":46914983400.73},{"date":"2024-09-27","current":44.008604,"twenty":15.841528,"median":31.485125,"eighty":81.717782,"marketCap":46173769906.47},{"date":"2024-10-04","current":44.8226,"twenty":15.841528,"median":31.485125,"eighty":81.193902,"marketCap":45207064894.75},{"date":"2024-10-11","current":45.034027,"twenty":15.841528,"median":31.485125,"eighty":80.903118,"marketCap":45273197191.14},{"date":"2024-10-18","current":45.203169,"twenty":15.841528,"median":31.485125,"eighty":80.121066,"marketCap":45314702691.87},{"date":"2024-10-25","current":43.395465,"twenty":15.841528,"median":31.485125,"eighty":79.259288,"marketCap":42802477236.79},{"date":"2024-11-01","current":23.34074,"twenty":15.841528,"median":31.394177,"eighty":76.252009,"marketCap":44255337707.7},{"date":"2024-11-08","current":23.061963,"twenty":15.841528,"median":31.223737,"eighty":52.659045,"marketCap":43818726338.15},{"date":"2024-11-15","current":23.302476,"twenty":15.841528,"median":30.720073,"eighty":52.113395,"marketCap":43649113935.95},{"date":"2024-11-22","current":22.482544,"twenty":15.841528,"median":30.492581,"eighty":51.914978,"marketCap":42094765685.01},{"date":"2024-11-29","current":22.318557,"twenty":15.841528,"median":30.428162,"eighty":51.719171,"marketCap":43004121919.03},{"date":"2024-12-06","current":22.537206,"twenty":15.841528,"median":30.363743,"eighty":51.54686,"marketCap":43593417925.5},{"date":"2024-12-13","current":22.602801,"twenty":15.841528,"median":30.265696,"eighty":51.06387,"marketCap":42654808427.14},{"date":"2024-12-20","current":22.438814,"twenty":15.841528,"median":30.156169,"eighty":50.729692,"marketCap":41620825476.96},{"date":"2024-12-27","current":22.89251,"twenty":15.841528,"median":30.11976,"eighty":50.270198,"marketCap":42157933916.75},{"date":"2025-01-03","current":22.854246,"twenty":15.841528,"median":30.084614,"eighty":49.695831,"marketCap":42120101324.52},{"date":"2025-01-10","current":22.526274,"twenty":15.834252,"median":30.039538,"eighty":48.706353,"marketCap":41387819255.78},{"date":"2025-01-17","current":22.072578,"twenty":15.834252,"median":29.98139,"eighty":47.742982,"marketCap":40954868347.09},{"date":"2025-01-24","current":22.056179,"twenty":15.834252,"median":29.928964,"eighty":47.376261,"marketCap":41086375616.12},{"date":"2025-01-31","current":32.066996,"twenty":15.834252,"median":29.8898,"eighty":47.184847,"marketCap":43068627249.87},{"date":"2025-02-07","current":31.518451,"twenty":15.834252,"median":29.8898,"eighty":46.698609,"marketCap":43370831342.3},{"date":"2025-02-14","current":31.625402,"twenty":15.834252,"median":29.8898,"eighty":46.623803,"marketCap":43271885610.15},{"date":"2025-02-21","current":32.135858,"twenty":15.834252,"median":29.8898,"eighty":46.463276,"marketCap":44737299221.36},{"date":"2025-02-28","current":33.019632,"twenty":15.834252,"median":29.8898,"eighty":46.1861,"marketCap":45710719655.87},{"date":"2025-03-07","current":33.965435,"twenty":15.826975,"median":29.881968,"eighty":45.994515,"marketCap":47968574450.17},{"date":"2025-03-14","current":32.579894,"twenty":15.826975,"median":29.881968,"eighty":45.856479,"marketCap":45709305301.84},{"date":"2025-03-21","current":33.462021,"twenty":15.826975,"median":29.881968,"eighty":45.756962,"marketCap":46697220950.86},{"date":"2025-03-28","current":32.837181,"twenty":15.826975,"median":29.881968,"eighty":45.646342,"marketCap":45537525126.69},{"date":"2025-04-04","current":32.910692,"twenty":15.826975,"median":29.881968,"eighty":45.486482,"marketCap":46959977925.4},{"date":"2025-04-11","current":28.911716,"twenty":15.834252,"median":29.864508,"eighty":45.423604,"marketCap":41903036554.51},{"date":"2025-04-17","current":30.516053,"twenty":15.834252,"median":29.864508,"eighty":45.37687,"marketCap":44665727413.14},{"date":"2025-04-25","current":31.299454,"twenty":15.826975,"median":29.853656,"eighty":45.205165,"marketCap":45236702475.67},{"date":"2025-05-02","current":32.353752,"twenty":15.826975,"median":29.853656,"eighty":45.143969,"marketCap":46627023849.03},{"date":"2025-05-09","current":62.186826,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":46246122430},{"date":"2025-05-16","current":59.013194,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":43629573670.78},{"date":"2025-05-23","current":60.272181,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":45243750600.82},{"date":"2025-05-30","current":62.428377,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":46713186360.41},{"date":"2025-06-06","current":62.153426,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":46690667816.43},{"date":"2025-06-13","current":62.934861,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":47259274399.65},{"date":"2025-06-20","current":62.052124,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":45950911927.98},{"date":"2025-06-27","current":63.18087,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47191840400.65},{"date":"2025-07-03","current":64.005724,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47693415916.83},{"date":"2025-07-11","current":64.055104,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47209686047.66},{"date":"2025-07-18","current":63.513752,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46158538139.51},{"date":"2025-07-25","current":63.308916,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46555456308.17},{"date":"2025-08-01","current":48.106805,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":43759985637.51},{"date":"2025-08-08","current":48.654381,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":45191185373.67},{"date":"2025-08-15","current":50.297108,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46622420863.67},{"date":"2025-08-22","current":52.350517,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":48379407617.45},{"date":"2025-08-29","current":50.434002,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46969989485.26},{"date":"2025-09-05","current":52.179399,"twenty":15.818034,"median":29.83907,"eighty":45.065741,"marketCap":48057469940.35},{"date":"2025-09-12","current":51.255365,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47683369897.6},{"date":"2025-09-19","current":51.084248,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47282912126.15},{"date":"2025-09-26","current":50.627935,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46290416349.68},{"date":"2025-10-03","current":48.574526,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":45123442627.46},{"date":"2025-10-10","current":48.163844,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":43057554125.18},{"date":"2025-10-17","current":47.810202,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":43420086875.26},{"date":"2025-10-24","current":49.008023,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":43939898848.11},{"date":"2025-10-31","current":196.128812,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":42096877735.37},{"date":"2025-11-07","current":199.628241,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":43122516182.74},{"date":"2025-11-14","current":212.188582,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":45471927947.27},{"date":"2025-11-21","current":211.902035,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":44500274886.11},{"date":"2025-11-28","current":215.197333,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":45545101317.81},{"date":"2025-12-05","current":210.61257,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":45011991214.34},{"date":"2025-12-12","current":212.427372,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":45254225772.44},{"date":"2025-12-19","current":219.877613,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":46788038894.3},{"date":"2025-12-26","current":232.581228,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":49307900125.5},{"date":"2026-01-02","current":230.9097,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":48729268900.59},{"date":"2026-01-09","current":242.610705,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":51132650268.4},{"date":"2026-01-16","current":242.276399,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":50569808771.94},{"date":"2026-01-23","current":244.329994,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":51041613744.96},{"date":"2026-01-30","current":73.324517,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":54139767928.12},{"date":"2026-02-06","current":77.171186,"twenty":15.819699,"median":29.842804,"eighty":45.118598,"marketCap":55518181293.68}],"updateTime":1770610893725},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TAK\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609590057","title":"Takeda’s TAK-188 Trial: Early Immunotherapy Bet in Advanced Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2609590057","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609590057?lang=en_us&edition=fundamental","pubTime":"2026-02-07 00:32","pubTimestamp":1770395525,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Study OverviewThis Takeda-sponsored trial, officially tit...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takedas-tak-188-trial-early-immunotherapy-bet-in-advanced-solid-tumors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takedas-tak-188-trial-early-immunotherapy-bet-in-advanced-solid-tumors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TAK","IE00B66KJ199.SGD","BK4157","LU0757428866.USD","AEIS","IE00B7SZL793.SGD","IE0031619046.USD","IE00B19Z4B17.USD","BK4007","LU1815336091.USD"],"gpt_icon":0},{"id":"2609590084","title":"Takeda Advances TAK-360 Sleep Disorder Trial, Signaling Growing Ambition in Orexin-Based Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2609590084","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609590084?lang=en_us&edition=fundamental","pubTime":"2026-02-07 00:31","pubTimestamp":1770395514,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Study OverviewThis Phase 2 study, officially titled “A Do...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takeda-advances-tak-360-sleep-disorder-trial-signaling-growing-ambition-in-orexin-based-therapies?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takeda-advances-tak-360-sleep-disorder-trial-signaling-growing-ambition-in-orexin-based-therapies?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TAK","BK4007"],"gpt_icon":0},{"id":"2607284040","title":"Takeda Advances TAK-279 in Ulcerative Colitis: What Investors Should Watch Next","url":"https://stock-news.laohu8.com/highlight/detail?id=2607284040","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607284040?lang=en_us&edition=fundamental","pubTime":"2026-01-31 00:33","pubTimestamp":1769790786,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Study Overview: Takeda is running a Phase 2 study called ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takeda-advances-tak-279-in-ulcerative-colitis-what-investors-should-watch-next?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takeda-advances-tak-279-in-ulcerative-colitis-what-investors-should-watch-next?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ISBC","BK4211","TAK","BK4007"],"gpt_icon":0},{"id":"2607303354","title":"Takeda Flags Vyvanse Hit, Lifts 2025 Profit Guidance On Cost Control","url":"https://stock-news.laohu8.com/highlight/detail?id=2607303354","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607303354?lang=en_us&edition=fundamental","pubTime":"2026-01-29 22:11","pubTimestamp":1769695893,"startTime":"0","endTime":"0","summary":"Takeda missed Q3 earnings estimates as Vyvanse generic pressure weighed on sales, but raised its 2025 profit forecast on cost discipline and favorable currency moves.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/earnings/26/01/50229026/takeda-flags-vyvanse-hit-lifts-2025-profit-guidance-on-cost-control","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1894683348.USD","TAK","BK4208","LU1003077747.HKD","LU2346227817.USD","BK4007","LU2500361329.USD","CMS","BK4585","LU0553294199.USD","LU0738911758.USD","LU1894683264.USD","ADHD","LU2637428348.USD","LU0661504455.SGD","LU0545039389.USD","BK4588","LU0949170772.SGD"],"gpt_icon":0},{"id":"2607083625","title":"Takeda raises FY25 core EPS view to 486 yen from 479 yen","url":"https://stock-news.laohu8.com/highlight/detail?id=2607083625","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607083625?lang=en_us&edition=fundamental","pubTime":"2026-01-29 18:35","pubTimestamp":1769682930,"startTime":"0","endTime":"0","summary":"Raises FY25 revenue view to 4.53B yen from 4.5B yen. The company said, “Takeda (TAK) has updated its full year Management Guidance for Revenue prim...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/takeda-raises-fy25-core-eps-view-to-486-yen-from-479-yen-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/takeda-raises-fy25-core-eps-view-to-486-yen-from-479-yen-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TAK"],"gpt_icon":0},{"id":"2607836570","title":"Takeda reports Q3 core EPS 428 yen vs. 443 yen last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2607836570","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607836570?lang=en_us&edition=fundamental","pubTime":"2026-01-29 18:30","pubTimestamp":1769682636,"startTime":"0","endTime":"0","summary":"Reports Q3 revenue 3.41B yen vs. 3.53B yen last year. Takeda (TAK) chief financial officer, Milano Furuta, commented: “While we manage the impact o...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/takeda-reports-q3-core-eps-428-yen-vs-443-yen-last-year-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/takeda-reports-q3-core-eps-428-yen-vs-443-yen-last-year-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TAK"],"gpt_icon":0},{"id":"2607708071","title":"Takeda Pharmaceutical Q3 Adj. EPS $0.47 Misses $0.55 Estimate, Sales $7.600B Miss $8.530B Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2607708071","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607708071?lang=en_us&edition=fundamental","pubTime":"2026-01-29 14:58","pubTimestamp":1769669888,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical (NYSE:TAK) reported quarterly earnings of $0.47 per share which missed the analyst consensus estimate of $0.55 by 13.64 percent. This is a 7.95 percent increase over earnings of $0.44 per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/01/50216195/takeda-pharmaceutical-q3-adj-eps-0-47-misses-0-55-estimate-sales-7-600b-miss-8-530b-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TAK","BK4007"],"gpt_icon":0},{"id":"2607086647","title":"Press Release: Takeda Reports Third-Quarter FY2025 Results: Updates Full Year Outlook to Reflect VYVANSE(R) Generics Impact, OPEX Discipline and FX Tailwind; Progressing Toward Three Transformative Launches Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2607086647","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607086647?lang=en_us&edition=fundamental","pubTime":"2026-01-29 14:37","pubTimestamp":1769668620,"startTime":"0","endTime":"0","summary":"--  Year-to-Date Revenue Declined by 2.8% at Constant Exchange Rate ,--  Core Operating Profit Declined by 3.4% at both CER and AER Year to Date. --  Reported Operating Profit Increased by 1.2% at AER Year to Date, Lower. Takeda is positioned for long-term growth and has multiple late-stage programs with multibillion-dollar peak revenue potential. Following the positive readouts from Phase 3 studies in 2025, the company has submitted New Drug Applications  for oveporexton and rusfertide and is on track to file an NDA for zasocitinib. Each of these programs, which Takeda expects to launch within the next 18 months, has the potential to redefine standards of care, transform patient lives and contribute to Takeda's new growth trajectory.\"FY2025 remains a truly pivotal year for Takeda as we are in a phase of preparing for significant new product launches. Looking ahead, with multiple innovative launches and a robust late-stage pipeline, Takeda is positioned to bring life-transforming medic","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","BK4572","BK4104","BK4007","LU0211331839.USD","OPEX","BK4022","LU1098665638.USD","R","TAK","AER","LU0109981661.USD"],"gpt_icon":0},{"id":"2606838711","title":"Medicare is about to start negotiating the prices of medications administered by doctors","url":"https://stock-news.laohu8.com/highlight/detail?id=2606838711","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606838711?lang=en_us&edition=fundamental","pubTime":"2026-01-28 21:07","pubTimestamp":1769605620,"startTime":"0","endTime":"0","summary":"The 15 drugs selected for negotiation include Eli Lilly's breast-cancer drug Verzenio. CMS Administrator Mehmet Oz said the agency is taking \"strong action\" to address drug costs under Medicare. . The U.S. plans to negotiate the prices of 15 more medications covered by Medicare, including two of Eli Lilly's top-selling drugs - though there were few surprises.The Centers for Medicare and Medicaid Services on Tuesday announced the third round of drugs included in the Medicare Drug Price Negotiation Program.\"CMS is taking strong action to target the most expensive drugs in Medicare, negotiate fair prices, and make sure the system works for patients - not special interests,\" CMS Administrator Mehmet Oz said in a statement.This time, the program includes, for the first time, medicines covered by Part B, which are drugs administered by clinicians in outpatient settings, in addition to those covered by Medicare Part D, which handles medications you can pick up at a pharmacy.The pharmaceutical","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0266013472.USD","LU0306807586.USD","LU2602419157.SGD","IE00BJJMRY28.SGD","LU2237443549.SGD","IE00BWXC8680.SGD","LU0070217475.USD","LU0310800379.SGD","LU0122379950.USD","LU1323610961.USD","LU0158827948.USD","LU1035775433.USD","IE00B1XK9C88.USD","LU0098860793.USD","LU2063271972.USD","RHHBY","IE00B7KXQ091.USD","LU2361045086.USD","LU2242646821.SGD","LU1221951129.SGD","LU1720051017.SGD","LU2125154778.USD","LU2491049909.HKD","LU0511384066.AUD","LU2087625088.SGD","IE00BFSS8Q28.SGD","BK4568","LU0471298777.SGD","LU2471134952.CNY","IE00BBT3K403.USD","LU0795875086.SGD","SG9999018865.SGD","LU1814569148.SGD","LU2324357040.USD","LU2505996681.GBP","LU2129689431.USD","SGXZ81514606.USD","LU1496350171.SGD","LU0061475181.USD","LU0128525929.USD","LU2456880835.USD","LU1989771016.USD","LU1868836591.USD","LU2461242641.AUD","IE00BSNM7G36.USD","LU1868837300.USD","LU0985320562.USD","LU2471134879.HKD","LU2168564495.EUR","IE00BLSP4239.USD","LU2552382215.SGD","LU2357305700.SGD","LU0882574139.USD","ABBV","GILD","LU2430703095.HKD","IE00BLSP4452.SGD","LU2471134796.USD","LU0237698245.USD","LU1804176565.USD","IE00BK4W5L77.USD","LU2168564222.USD","LU1934455863.HKD","LU1003077747.HKD","BK4588","LU0321505439.SGD","IE00B19Z3B42.SGD","LU0353189763.USD","LU0198837287.USD","LU0345770308.USD","LU0689626769.HKD","LU0689472784.USD","LU2360032135.SGD","LU1267930813.SGD","LU0385154629.USD","LU2491050071.SGD","LU1917777945.USD","LU1057294990.SGD","SG9999003800.SGD","LU2896262040.SGD","LU1988902786.USD","LU0057025933.USD","LU2089984988.USD","LU0323591593.USD","LU0820561818.USD","LU0708995401.HKD","SG9999014880.SGD","LU1732800096.USD","LU0211331839.USD","LU0029864427.USD","LU2361044949.HKD","LU0114720955.EUR","LU0225284248.USD","LU1074936037.SGD","LU0708994859.HKD","LU1032466523.USD","LU1974910355.USD","LU2360106947.USD","LU0823434740.USD","LU2265009873.SGD","LU1244550494.USD","IE00B3PB1722.GBP","LU0683600562.USD","LU0345770993.USD","SGXZ57979304.SGD","LU1162221912.USD","LU2236285917.USD","LU2462157665.USD","LU1934455277.USD","IE0002270589.USD","LLY","IE00B775H168.HKD","LU0097036916.USD","IE0009355771.USD","IE00BZ1G4Q59.USD","LU1670711040.USD","LU1894683348.USD","LU1712237335.SGD","IE00BJLML261.HKD","LU1037948897.HKD","LU0795875169.SGD","BK4592","LU1066051225.USD","LU1221951046.USD","LU1061106388.HKD","LU1670711123.USD","LU2468319806.SGD","LU1718418525.SGD","LU0234572021.USD","LU0320765992.SGD","LU0225283273.USD","LU0106261372.USD","BK4139","LU0225771236.USD","LU2106854487.HKD","SG9999001176.USD","BK4578","LU0353189680.USD","LU2168564149.EUR","GSK","LU1551013425.SGD","LU0985481810.HKD","LU0823416689.USD","LU0471298694.HKD","LU2023250504.SGD","LU0456855351.SGD","LU2552382132.HKD","IE00B3T34201.USD","BK4504","IE0034235303.USD","LU0316494557.USD","LU2125154935.USD","LU2111349929.HKD","SG9999011175.SGD","SG9999015978.USD","LU1778281490.HKD","LU1496350502.SGD","BK4566","LU1066051498.USD","LU2237443895.HKD","LU0256863902.USD","BK4533","IE0004445015.USD","LU2237443622.USD","LU1366192091.USD","LU0965509101.SGD","LU0069063385.USD","LU2028103732.USD","BK4585","LU2746668461.USD","LU1934455194.USD","LU0466842654.USD","LU1674673428.USD","TAK","LU0738911758.USD","IE00BKDWB100.SGD","LU1989772923.USD","LU1670710661.SGD","LU1261432733.SGD","LU1989772840.SGD","LU2089284900.SGD","LU0058720904.USD","LU0070302665.USD","LU1069344957.HKD","IE00BDGV0183.EUR","LU0882574055.USD","SG9999014898.SGD","IE00B19Z3581.USD","LU0640476718.USD","BK4532","LU1059921491.USD","LU1267930573.SGD","LU0672654240.SGD","LU1244550577.SGD","IE0002141913.USD","LU0661504455.SGD","IE00BFXG1179.USD","LU2237443465.HKD","LU0345769631.USD","LU1430594728.SGD","LU1894683264.USD","IE00B1BXHZ80.USD","IE00BJJMRX11.SGD","LU1267930730.SGD","SG9999002232.USD","LU1868837136.USD","IE00BJJMRZ35.SGD","LU2089283258.USD","LU1929549753.HKD","BK4516","LU0345769128.USD","LU1023059063.AUD","IE00B4JS1V06.HKD","IE00BKPKM429.USD","SGXZ51526630.SGD","LU2552382058.USD","LU0861579265.USD","LU1720051108.HKD","BK4007","LU0320765646.SGD","LU2471134523.USD","SGXZ99366536.SGD","GSK.UK","LU2023251221.USD","LU0211327993.USD","BK4534","LU0096364046.USD","LU2750360997.AUD","LU1935042991.SGD","SG9999002224.SGD","BMY","LU1670710588.SGD","LU2133065610.SGD","LU0912757837.SGD","LU1623119135.USD","BK4559","LU2430703178.SGD","IE00B4R5TH58.HKD","SG9999015952.SGD","LU1732799900.SGD","LU0786609619.USD","LU1506573853.SGD","LU0823434583.USD","LU2087621335.USD","LU0158827781.USD","IE00BVYPNV92.GBP","LU1674673691.USD","LU1551013342.USD","LU2242652126.USD","SG9999014906.USD","LU0792757196.USD","IE00BN29S564.USD","LU2746668974.SGD","BK4581","LU0472753341.HKD","LU0208291251.USD","LU0417517546.SGD","SG9999015945.SGD","LU0310799852.SGD","LU0203345920.USD","LU2112291526.USD","LU0965509010.AUD","LU0354030438.USD","LU1232071149.USD","LU0321505868.SGD","LU1585245621.USD","LU0289739343.SGD","IE00BFSS7M15.SGD","LU1839511570.USD","LU2491050154.USD","LU1244550221.USD","LU1883839398.USD","IE00B42XCP33.USD","LU0203347892.USD","LU1032955483.USD","LU1093756168.USD","LU2237438978.USD","GB00BDT5M118.USD","IE00B7SZLL34.SGD","LU0965508806.USD","SG9999001176.SGD","LU0170899867.USD","IE000M9KFDE8.USD","LU2129689514.USD","LU2750360641.GBP","LU2430703251.USD","LU1196500208.SGD","LU0203202063.USD","LU1127390331.HKD","LU1829250122.USD","SG9999001440.SGD","SG9999017495.SGD","LU0289961442.SGD","LU1066053197.SGD","LU0889565916.HKD","LU0109391861.USD","LU1280957306.USD","LU0545039389.USD","LU2168563687.JPY","LU2417539215.USD","LU0289739699.SGD","LU0432979614.USD","IE00B2B36J28.USD","LU0889566641.SGD","UCB","IE00BJT1NW94.SGD","LU1868836914.USD","LU1983299246.USD","LU2271345857.HKD","LU0306806265.USD","LU0094547139.USD","LU1914381329.SGD","LU0787776722.HKD","LU0109394709.USD","IE0004445239.USD","LU0354030511.USD","BK4599","BK4583","LU2129689605.HKD","LU0553294199.USD","LU0949170772.SGD","IE00BN8TJ469.HKD","LU2108987350.USD","LU0124676726.USD","IE00BFTCPJ56.SGD","LU0320765489.SGD","JNJ","LU0320765059.SGD","LU0234570918.USD","LU2211815571.USD","LU0820561909.HKD","LU0079474960.USD","BK4550","LU2592432038.USD","LU0211328371.USD","LU2237443978.SGD","IE00BKVL7J92.USD","SG9999015986.USD","LU2237443382.USD","NVS","LU1548497426.USD","LU2168564065.EUR","IE00BVYPNW00.USD","LU1291159041.SGD","LU1267930490.SGD","IE00BK4W5M84.HKD","LU0238689110.USD","LU2347655156.SGD","SGXZ31699556.SGD","SG9999013999.USD","LU0256863811.USD","LU2264538146.SGD","LU0943347566.SGD","LU0210536198.USD","LU0965509283.SGD","LU0006306889.USD","IE00BGHQF631.EUR","LU0203201768.USD","LU2505996509.AUD","LU0868494617.USD","LU0267386448.USD","LU1868836757.USD","IE0005OL40V9.USD","LU1571399168.USD","SG9999018857.SGD","LU1037948541.HKD","LU1066051811.HKD","LU2361044865.SGD","LU1093756325.SGD","LU1064131342.USD","SG9999014914.USD"],"gpt_icon":1},{"id":"2606764504","title":"Takeda Expected to Report Sharply Higher Third-Quarter Net Profit -- Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2606764504","media":"Dow Jones","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606764504?lang=en_us&edition=fundamental","pubTime":"2026-01-28 13:41","pubTimestamp":1769578860,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical is scheduled to report its third-quarter results on Thursday. Here's what you need to know:. NET PROFIT FORECAST: Takeda's net profit is expected to have more than quadrupled to 107.9 billion yen, equivalent to $708.9 million, for the three months ended December, according to a poll of analysts by Visible Alpha. The company reported net profit of Y23.8 billion in the year-earlier period, which was weighed by restructuring expenses.REVENUE FORECAST: Third-quarter revenue is estimated to have increased 4.0% from a year earlier to Y1.190 trillion, according to the Visible Alpha poll.The stock has risen 6.1% year to date through Tuesday, following a 16% increase in 2025.--For the fiscal year ending March, Takeda projected revenue to decline 1.8% to Y4.500 trillion and net profit to increase 42% to Y153.00 billion. Investors will be closely watching any changes to annual guidance that management may make.--Second-quarter sales of plasma-derived products fell 2.9% to Y2","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TAK"],"gpt_icon":0},{"id":"2605906404","title":"Takeda Advances TAK-861 Into Phase 3 for Narcolepsy With Cataplexy, Setting Up a New CNS Catalyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2605906404","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605906404?lang=en_us&edition=fundamental","pubTime":"2026-01-24 00:33","pubTimestamp":1769186016,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Study Overview Takeda is launching a late-stage trial to ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takeda-advances-tak-861-into-phase-3-for-narcolepsy-with-cataplexy-setting-up-a-new-cns-catalyst?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takeda-advances-tak-861-into-phase-3-for-narcolepsy-with-cataplexy-setting-up-a-new-cns-catalyst?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TAK","CNS"],"gpt_icon":0},{"id":"1181003676","title":"Takeda's (TAK.US) New Class 1 Drug Oveporexton Tablets Recommended for Priority Review, Intended for Type 1 Narcolepsy Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=1181003676","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181003676?lang=en_us&edition=fundamental","pubTime":"2026-01-23 14:50","pubTimestamp":1769151025,"startTime":"0","endTime":"0","summary":"The China Center for Drug Evaluation (CDE) under the National Medical Products Administration (NMPA) recently announced that the marketing application for Takeda Pharmaceutical Co Ltd's (TAK.US) new...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TAK"],"gpt_icon":0},{"id":"2605492807","title":"Takeda Pharmaceutical Launches Liquid Medicine for Primary Immunodeficiency in US","url":"https://stock-news.laohu8.com/highlight/detail?id=2605492807","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605492807?lang=en_us&edition=fundamental","pubTime":"2026-01-22 22:04","pubTimestamp":1769090699,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical  said Thursday its Gammagard Liquid ERC therapy for primary immunodeficiency is now available in the US by prescription.The ready-to-use liquid therapy with low immunoglobulin A content is approved for intravenous or subcutaneous use in patients 2 years old and older with primary immunodeficiency, the company said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TAK","BK4007"],"gpt_icon":0},{"id":"1182940617","title":"Earning Preview: Takeda Pharmaceutical Co Ltd — this quarter’s revenue is expected to increase by 6.05%, and institutional views are constructive","url":"https://stock-news.laohu8.com/highlight/detail?id=1182940617","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182940617?lang=en_us&edition=fundamental","pubTime":"2026-01-22 11:35","pubTimestamp":1769052949,"startTime":"0","endTime":"0","summary":"Abstract Takeda Pharmaceutical Co Ltd will report fiscal quarter results on January 29, 2026 Pre-Market; the preview below compiles current-quarter forecasts, last-quarter performance, and the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Earning Preview: Takeda Pharmaceutical Co Ltd — this quarter’s revenue is expected to increase by 6.05%, and institutional views are constructive","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TAK"],"gpt_icon":0},{"id":"2605818954","title":"Takeda’s TAK-411 CIDP Study Progresses: What Investors Should Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2605818954","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605818954?lang=en_us&edition=fundamental","pubTime":"2026-01-22 00:36","pubTimestamp":1769013419,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Study Overview: Takeda is running a Phase 2 proof-of-conc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takedas-tak-411-cidp-study-progresses-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takedas-tak-411-cidp-study-progresses-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TAK","ISBC","BK4007","BK4211"],"gpt_icon":0},{"id":"1169849558","title":"Takeda Pharmaceutical's (TAK.US) New Class 1 Drug \"Oboletong Tablets\" Files for Market Approval in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1169849558","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169849558?lang=en_us&edition=fundamental","pubTime":"2026-01-16 15:38","pubTimestamp":1768549115,"startTime":"0","endTime":"0","summary":"On January 16, the latest official announcement from the Center for Drug Evaluation (CDE) of China's National Medical Products Administration revealed that the market application for the new Class 1...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TAK","BK4007"],"gpt_icon":0},{"id":"2603612381","title":"Oncolytics Biotech® Appoints John McAdory as EVP of Strategy and Operations and Yujun Wu to Lead Biostatistics","url":"https://stock-news.laohu8.com/highlight/detail?id=2603612381","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603612381?lang=en_us&edition=fundamental","pubTime":"2026-01-14 22:00","pubTimestamp":1768399200,"startTime":"0","endTime":"0","summary":"Appointments strengthen late-stage clinical execution and statistical leadership as the Company advances multiple registration-directed programs in gastrointestinal cancersSAN DIEGO, Jan.  14, 2026  (","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/14/3218710/0/en/Oncolytics-Biotech-Appoints-John-McAdory-as-EVP-of-Strategy-and-Operations-and-Yujun-Wu-to-Lead-Biostatistics.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TAK","BK4007","EVP"],"gpt_icon":0},{"id":"2602392072","title":"Leerink views ‘major deal’ on Entyvio as positive for Halozyme","url":"https://stock-news.laohu8.com/highlight/detail?id=2602392072","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602392072?lang=en_us&edition=fundamental","pubTime":"2026-01-09 02:40","pubTimestamp":1767897615,"startTime":"0","endTime":"0","summary":"Leerink notes Halozyme (HALO) issued a press release announcing that it entered into an exclusive license agreement with Takeda (TAK) in December 2...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/leerink-views-major-deal-on-entyvio-as-positive-for-halozyme-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/leerink-views-major-deal-on-entyvio-as-positive-for-halozyme-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TAK","BK4139","BK4007","LU0053671581.USD","HALO"],"gpt_icon":0},{"id":"2601536282","title":"Halozyme announces global collaboration, license agreement with Takeda","url":"https://stock-news.laohu8.com/highlight/detail?id=2601536282","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601536282?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:11","pubTimestamp":1767877904,"startTime":"0","endTime":"0","summary":"Halozyme Therapeutics (HALO) announced the company entered into a global collaboration and exclusive license agreement with Takeda (TAK) in Decembe...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/halozyme-announces-global-collaboration-license-agreement-with-takeda-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/halozyme-announces-global-collaboration-license-agreement-with-takeda-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TAK","BK4139","BK4007","LU0053671581.USD","HALO"],"gpt_icon":0},{"id":"2592413445","title":"Takeda Pharmaceuticals Shares Rise on Positive Psoriasis Treatment Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2592413445","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592413445?lang=en_us&edition=fundamental","pubTime":"2025-12-19 11:17","pubTimestamp":1766114220,"startTime":"0","endTime":"0","summary":"Shares of Takeda Pharmaceuticals rose after the Japanese pharmaceutical major announced positive results from clinical trials of its new treatment for plaque psoriasis.The stock climbed 4.3% in early Tokyo trade Friday to reach a three-month high before pulling back slightly. It is on course for its biggest single-day gain since April.The benchmark Nikkei Stock Average was last up 1.2%.Takeda's gains came after it said its drug candidate zasocitinib delivered positive results in Phase 3 studies, the final stage of clinical trials before regulatory approval.The new drug is designed to treat moderate to severe plaque psoriasis, a condition that causes raised, itchy and painful skin patches covered by scales. An estimated 64 million people globally have psoriasis with 80%-90% of them having plaque psoriasis specifically, medical studies show.The drug, delivered in a once-a-day pill, achieved complete or near-complete clearance of skin lesions in more than half of the trial participants, T","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Takeda Pharmaceuticals Shares Rise on Positive Psoriasis Treatment Results","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TAK","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":55,"code":"91000000","status":"200"}]}}